SCHEMBL21590399

SCHEMBL21590399

Cc1cc(Cl)cc(NC(=O)OC(C)(C)C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 1/20 0.41
PTGER1 P34995 2/20 0.40
LCK P06239 5/20 0.40
ATR Q13535 1/20 0.40
SCN9A Q15858 1/20 0.40
PHGDH O43175 1/20 0.40
CYP2C9 P11712 1/20 0.39
GSK3B P49841 1/20 0.39
DYRK1A Q13627 1/20 0.39
LMNA P02545 1/20 0.38
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
CASP3 P42574 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31248850 0.88 ATR (0.45) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL16147173 0.88 ATR (0.45) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL30711674 0.84 LCK (0.51) CYP1A2CYP3A4LCKLMNAKMT2A
SCHEMBL2113744 0.84 LCK (0.51) CYP1A2CYP3A4LCKLMNAKMT2A
SCHEMBL31235341 0.84 LCK (0.39) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL23467642 0.82 LCK (0.48) LCKSCN9AGSK3BDYRK1ANPC1
SCHEMBL29955764 0.81 ATR (0.40) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL3327320 0.81 SCN9A (0.40) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL3329005 0.81 S1PR2 (0.41) PTGER1LCKATRSCN9ACYP2C9
SCHEMBL4443611 0.80 LCK (0.41) PTGER1LCKATRSCN9ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024249817-A1 TRICYCLIC PKMYT1 KINASE INHIBITORS ENLIVEN INC. (US) 2024-12-05 WO disclosed
WO-2021178488-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. (US) 2021-09-10 WO disclosed
EP-3807271-A1 PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
CN-112585134-A Pyridyl heterocyclyl compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2021-03-30 CN disclosed
WO-2019238629-A1 PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed
WO-2019238629-A1 PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed